Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: A two‑edged weapon in chronic fatigue syndrome
- Authors: Annamaria Pasi, Sara Bozzini, Nicoletta Carlo-Stella, Miryam Martinetti, Stefano Bombardieri, Annalisa De Silvestri, Laura Salvaneschi, Mariaclara Cuccia
Published online on: Friday, March 4, 2011
- Pages: 535-540
- DOI: 10.3892/mmr.2011.447
Chronic fatigue syndrome (CFS) is an inflammatory disease of unknown aetiology. Researchers have proposed infectious, neurological and immunological causes of this syndrome. Recently, the xenotropic murine leukemia virus-related virus was detected in 67% of patients with CFS in a US study. This observation is in agreement with one ascertained aspect of the disease: a decreased efficiency in NK cell lytic activity in CFS patients. Here, we analyzed the genomic polymorphism of killer cell immunoglobulin-like receptors (KIRs) and their HLA class I cognate ligands in patients with certified CFS. An excess of KIR3DS1 was found in CFS patients with respect to controls, as well as an increased frequency of the genotype missing KIR2DS5. Forty-four CFS patients and 50 controls also underwent genomic typing for the HLA-ligands. In the patients, a great proportion of KIR3DL1 and KIR3DS1 receptors were found to be missing their HLA-Bw4Ile80 binding motif. We hypothesize that an excess of KIR3DS1, combined with an excess of ligand-free KIR3DL1 and KIR3DS1 receptors, may hamper the clearance of a pathogen via NK cells, thus favouring the chronicity of the infection.